Anat Ashkenazi

Anat Ashkenazi

Director of Finance/CFO at ALPHABET INC.

Net worth: 48 M $ as of 2026-05-30

53 year
Health Technology
Technology Services
Consumer Services

Profile

Anat Ashkenazi is on the board of Varian Medical Systems, Inc. and Maravai Lifesciences Holdings, Inc. and Chief Financial Officer & Senior Vice President at Eli Lilly & Co. Ms. Ashkenazi previously was Chief Financial Officer, Controller & Senior VP at Lilly Research Laboratories. Anat Ashkenazi received an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Tel-Aviv University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-24 126,830 ( 0% ) 48 M $ 2026-05-30

Anat Ashkenazi active positions

CompaniesPositionStart
ALPHABET INC. Director of Finance/CFO 2024-07-30
Director/Board Member -
Director of Finance/CFO 2024-07-30

Former positions of Anat Ashkenazi

CompaniesPositionEnd
MARAVAI LIFESCIENCES HOLDINGS, INC. Director/Board Member 2024-07-30
ELI LILLY AND COMPANY Director of Finance/CFO 2024-07-14
VARIAN MEDICAL SYSTEMS, INC. Director/Board Member 2021-04-14
Lilly Diabetes
Director of Finance/CFO -
Director of Finance/CFO -
See the detail of Anat Ashkenazi's experience

Training of Anat Ashkenazi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Technology Services

Consumer Services

Consumer Services

Commercial Services

Lilly Diabetes

Finance

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Anat Ashkenazi
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!